In July, 2011, the FDA issued a warning against transvaginal mesh devices because of their serious complications. This warning supplements an initial FDA warning against these devices made in 2008.
More than 1,000 women have reported to the FDA serious complications with the transvaginal mesh devices. Also, according to a study done in 2009, within three months, 15% of women experienced erosion of the mesh device, a very serious complication. The effectiveness of these devices is being seriously evaluated by the FDA and other healthcare professionals. The FDA further asserts that the transvaginal mesh devices are no more beneficial than other vaginal surgeries yet pose more serious health risks to women.
The attorneys at Arias Sanguinetti Wang & Torrijos are currently investigating the claims against manufacture of transvaginal mesh devices. If you have had a mesh device implanted and are experiencing serious complications or discomfort, contact the attorneys at Arias Sanguinetti Wang & Torrijos today.
The transvaginal mesh devices are used in women who have suffered pelvic organ prolapse (POP). Pelvic organ prolapse occurs when the typical support of the vagina decreases, causing the bladder, urethra, cervix, or rectum to sag or drop. The mesh device is used to hold these organs in place and prevent them from dropping or sagging. It stitches the connective tissues in the vaginal wall muscle back together.
Transvaginal mesh devices are causing serious complications in women who have had pelvic organ prolapse. Contact an attorney if you have experienced any of the following complications:
If you or someone you know has had similar complications with transvaginal mesh devices, you may be entitled to compensation for your injuries and medical bills. The Los Angeles transvaginal mesh defect attorneys at Arias Sanguinetti Wang & Torrijos are currently investigating complaints against these mesh devices. To discuss your legal options, contact our attorneys today for a free consultation.